UROTHELIAL CARCINOMA OF THE BLADDER
Clinical trials for UROTHELIAL CARCINOMA OF THE BLADDER explained in plain language.
Never miss a new study
Get alerted when new UROTHELIAL CARCINOMA OF THE BLADDER trials appear
Sign up with your email to follow new studies for UROTHELIAL CARCINOMA OF THE BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Bladder cancer trial combines immunotherapy with chemo to boost remission
Disease control OngoingThis study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy helps people with bladder cancer that has spread to nearby lymph nodes. About 60 participants will receive either chemo alone or chemo plus durvalumab, followed by maintenance durvalumab fo…
Matched conditions: UROTHELIAL CARCINOMA OF THE BLADDER
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Urine test may spare bladder cancer patients from frequent scopes
Diagnosis OngoingThis study is testing a urine test called BladMetrix to see if it can detect bladder cancer returning after surgery. 500 adults with non-muscle invasive bladder cancer will provide urine samples during routine follow-up visits over 2 years. The test's accuracy will be compared to…
Matched conditions: UROTHELIAL CARCINOMA OF THE BLADDER
Sponsor: Oslo University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:05 UTC